UNSPSC 51372031: Morphine hydrochloride

This classification denotes an opioid receptor agonist with the molecular formula C17H19NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J28GE0ROVX, chemically known as morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, hydrochloride, (5-alpha,6-alpha)- but more generally known as morphine hydrochloride, which bears US NIH Compound Identifier 5464110. European Medicines Agency schedules Morphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14596MIG.

UNSPSC 51372031 Morphine hydrochloride is a Commodity code; however, the recent state and local procurement activity associated with this code does not reflect pharmaceutical-grade morphine acquisition. Instead, Seminole County, Florida posted IFB 60459723LAS seeking procurement of naloxone (an opioid antagonist) and safe drug deactivation systems—products functionally unrelated to the code's nominal scope. The mismatch suggests either miscoding in the source system or that this Commodity code does not capture meaningful recent state and local contracting activity in its intended product category.

The single identifiable opportunity under this code originates from a Florida county health department. Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2026, targets annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract includes a two-year initial term plus one-year renewal option, E-Verify compliance, drug-free workplace certification, and standard insurance requirements; the procurement does not specify set-asides for disadvantaged enterprises and is potentially FEMA-funded. No additional state, county, or municipal opportunities under this code appear in the recent record. The geographic and issuing-body activity captured does not support reliable characterization of market concentration or regional procurement patterns for morphine hydrochloride itself.